BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2018 4:40:10 AM | Browse: 694 | Download: 689
Publication Name World Journal of Hepatology
Manuscript ID 39314
Country/Territory United States
Received
2018-04-11 06:34
Peer-Review Started
2018-04-11 07:53
To Make the First Decision
2018-05-02 03:41
Return for Revision
2018-05-03 06:23
Revised
2018-05-10 04:46
Second Decision
2018-05-22 09:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-05-24 03:37
Articles in Press
2018-05-24 03:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-10-19 00:23
Publish the Manuscript Online
2018-10-27 04:40
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Era of direct acting anti-viral agents for the treatment of hepatitis C
Manuscript Source Unsolicited Manuscript
All Author List Monjur Ahmed
ORCID
Author(s) ORCID Number
Monjur Ahmed http://orcid.org/0000-0003-0515-9224
Funding Agency and Grant Number
Corresponding Author Monjur Ahmed, FACG, FACP, MD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Thomas Jefferson University, 132 South 10th Street, Suite 468, Main Building, Philadelphia, PA 19107, United States. monjur.ahmed@jefferson.edu
Key Words Direct acting anti-viral agents; Hepatitis C virus infection; Post-liver transplant; Hepatitis C virus/human immunodeficiency virus co-infection
Core Tip Treatment of hepatitis C has now become much easy and simple with the advent of direct acting anti-viral agents (DAAs) against hepatitis C virus (HCV). Although the DAAs are highly effective in eradicating HCV infection, they have different mechanisms of action, side effects, resistance factors and drug-drug interactions. The treatment also varies in special situations like HCV/ human immunodeficiency virus co-infection and post-liver transplant patients. Physicians treating patients with HCV infection should have a clear knowledge about the DAAs as well as the current guidelines.
Publish Date 2018-10-27 04:40
Citation Ahmed M. Era of direct acting anti-viral agents for the treatment of hepatitis C. World J Hepatol 2018; 10(10): 670-684
URL http://www.wjgnet.com/1948-5182/full/v10/i10/670.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i10.670
Full Article (PDF) WJH-10-670.pdf
Full Article (Word) WJH-10-670.doc
Manuscript File 39314-Review.docx
Answering Reviewers 39314-Answering reviewers.pdf
Audio Core Tip 39314-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 39314-Conflict-of-interest statement.pdf
Copyright License Agreement 39314-Copyright assignment.pdf
Peer-review Report 39314-Peer-review(s).pdf
Scientific Misconduct Check 39314-Scientific misconduct check.pdf
Scientific Editor Work List 39314-Scientific editor work list.pdf